Inventor · disambiguated record
Colette Song
Also filed as: SONG COLETTE
213 granted patents·47 pending applications·962 citations·filing 2014–2025
99Inventor score
Top patents by PatentIndex Score
260 records- 0199US11890334B2Personalized immunotherapy against several neuronal and brain tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Feb 6, 2024·8 cites·20 claims
- 0299US11759507B2Personalized immunotherapy against several neuronal and brain tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Sep 19, 2023·9 cites·20 claims
- 0399US11618774B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Apr 4, 2023·6 cites·20 claims
- 0499US11607446B2Personalized immunotherapy against several neuronal and brain tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Mar 21, 2023·14 cites·20 claims
- 0599US11529401B2Personalized immunotherapy against several neuronal and brain tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Dec 20, 2022·14 cites·20 claims
- 0699US11529400B1Personalized immunotherapy against several neuronal and brain tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Dec 20, 2022·14 cites·20 claims
- 0799US11524059B2Personalized immunotherapy against several neuronal and brain tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Dec 13, 2022·14 cites·20 claims
- 0899US11498948B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Nov 15, 2022·4 cites·20 claims
- 0999US11479589B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Oct 25, 2022·4 cites·20 claims
- 1099US11414472B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Aug 16, 2022·3 cites·20 claims
- 1199US11414470B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Aug 16, 2022·6 cites·20 claims
- 1299US11407798B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Aug 9, 2022·6 cites·20 claims
- 1399US11401319B2Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Aug 2, 2022·3 cites·20 claims
- 1499US11370817B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jun 28, 2022·6 cites·20 claims
- 1599US11352401B1Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jun 7, 2022·4 cites·20 claims
- 1699US11324812B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted May 10, 2022·11 cites·20 claims
- 1799US11292821B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Apr 5, 2022·5 cites·20 claims
- 1899US11279741B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Mar 22, 2022·7 cites·20 claims
- 1999US11279740B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Mar 22, 2022·4 cites·20 claims
- 2099US11261224B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Mar 1, 2022·5 cites·20 claims
- 2199US11123370B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Sep 21, 2021·4 cites·20 claims
- 2299US11071773B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jul 27, 2021·8 cites·20 claims
- 2399US11058726B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jul 13, 2021·4 cites·20 claims
- 2499US11027002B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jun 8, 2021·8 cites·20 claims
- 2599US11001616B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted May 11, 2021·5 cites·20 claims
- 2699US10899810B2B*44 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·6 cites·20 claims
- 2799US10898560B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·11 cites·20 claims
- 2899US10899809B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·5 cites·20 claims
- 2999US10898559B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·11 cites·20 claims
- 3099US10836806B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Nov 17, 2020·27 cites·19 claims
- 3199US10526389B2Peptides and combinations of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Jan 7, 2020·14 cites·20 claims
- 3299US10071148B2Immunotherapy against several tumors, such as lung cancer, including NSCLCIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Sep 11, 2018·198 cites·16 claims
- 3399US9943579B2Immunotherapy against several tumors, such as lung cancer, including NSCLCIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Apr 17, 2018·131 cites·12 claims
- 3498US11890333B2Personalized immunotherapy against several neuronal and brain tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Feb 6, 2024·6 cites·20 claims
- 3598US11459365B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Oct 4, 2022·2 cites·20 claims
- 3698US11427622B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Aug 30, 2022·2 cites·20 claims
- 3798US11414471B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Aug 16, 2022·2 cites·20 claims
- 3898US11414473B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Aug 16, 2022·2 cites·20 claims
- 3998US11117941B2B*44 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Sep 14, 2021·3 cites·20 claims
- 4098US10925948B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Feb 23, 2021·12 cites·23 claims
- 4198US10899811B2B*44 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·5 cites·20 claims
- 4298US10842817B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Nov 24, 2020·4 cites·20 claims
- 4398US10780125B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Sep 22, 2020·4 cites·20 claims
- 4498US10577402B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Mar 3, 2020·12 cites·17 claims
- 4598US10550167B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Feb 4, 2020·12 cites·17 claims
- 4697US12005105B2Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jun 11, 2024·2 cites·20 claims
- 4797US11235042B2Peptides and combination of peptides for use in immunotherapy against various cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Feb 1, 2022·2 cites·20 claims
- 4897US11224644B2Peptides and combination of peptides for use in immunotherapy against various cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jan 18, 2022·2 cites·20 claims
- 4997US11208449B2Peptides for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Dec 28, 2021·3 cites·20 claims
- 5097US11168122B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Nov 9, 2021·2 cites·20 claims
Showing the top 50 of 260 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Colette Song files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →